Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease

Patients with diabetes and chronic kidney disease (CKD) are at particularly high risk for cardiovascular disease (CVD). This post hoc analysis from the PROspective pioglitAzone Clinical Trial In macroVascular Events (PROactive) investigated the relationship between CKD and incident CVD in a populati...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Schneider, Christian A., Ferrannini, Ele, DeFronzo, Ralph, Schernthaner, Guntram, Yates, John, Erdmann, Erland
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2008
Gaiak:
Clinical Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2391042/
https://ncbi.nlm.nih.gov/pubmed/18057215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2007060678
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak